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Abstract
Background: Inflammatory stimuli induce the hepatic iron regulatory hormone hepcidin, which contributes to anaemia
of inflammation (AI). Hepcidin expression is regulated by the bone morphogenetic protein (BMP) and the interleukin-6
(IL-6) signalling pathways. Prior results indicate that the BMP type I receptor ALK3 is mainly involved in the
acute inflammatory hepcidin induction four and 72 h after IL-6 administration. In this study, the role of ALK3 in
a chronic model of inflammation was investigated. The intact, heat-killed bacterium Brucella abortus (BA) was
used to analyse its effect on the development of inflammation and hypoferremia in mice with hepatocyte-
specific Alk3-deficiency (Alk3fl/fl; Alb-Cre) compared to control (Alk3fl/fl) mice.
Results: An iron restricted diet prevented development of the iron overload phenotype in mice with hepatocyte-
specific Alk3 deficiency. Regular diet leads to iron overload and increased haemoglobin levels in these mice, which
protects from the development of AI per se. Fourteen days after BA injection Alk3fl/fl; Alb-Cre mice presented milder
anaemia (Hb 16.7 g/dl to 11.6 g/dl) compared to Alk3fl/fl control mice (Hb 14.9 g/dl to 8.6 g/dl). BA injection led to an
intact inflammatory response in all groups of mice. In Alk3fl/fl; Alb-Cre mice, SMAD1/5/8 phosphorylation was reduced
after BA as well as after infection with Staphylococcus aureus. The reduction of the SMAD1/5/8 signalling pathway due
to hepatocyte-specific Alk3 deficiency partly suppressed the induction of STAT3 signalling.
Conclusion: The results reveal in vivo, that 1) hepatocyte-specific Alk3 deficiency partly protects from AI, 2) the
development of hypoferremia is partly dependent on ALK3, and 3) the ALK3/BMP/hepcidin axis may serve as a
possible therapeutic target to attenuate AI.
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Background
Patients with acute or chronic inflammatory diseases or
malignancies often develop anaemia of inflammation
(AI). More than a quarter of the world’s population is
anaemic. As the second most common form of anaemia,
AI contributes substantially to the burden of disease [1,
2]. Patients with AI present with hypoferremia, as iron is
trapped within the iron stores and iron bioavailability for
erythropoiesis is therefore decreased [3]. The hepatic
hormone hepcidin plays a major role in the maintenance
of iron homeostasis. Hepcidin induces internalization
and degradation of the sole known iron exporter ferro-
portin [4]. Induction of hepcidin decreases the bioavail-
ability of iron and can lead to an iron-restricted
erythropoiesis [5]. During inflammation, cytokines such
as the pro-inflammatory cytokine interleukin 6 (IL-6)
are induced [6]. IL-6 acts via the Janus kinase-signal
transducer (JAK) and activator of transcription (STAT3)
pathway. Hepcidin transcription is induced by binding of
phosphorylated STAT3 to the STAT3-responsive elem-
ent in the hepcidin promoter [7]. In addition, transcrip-
tional regulation of hepcidin requires BMP signalling [8].
Upon ligand binding, the BMP type II receptor is phos-
phorylated and thereby activates the BMP type I
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receptor. Activation of the kinase domain of the BMP
type I receptor phosphorylates SMAD (P-SMAD 1, 5,
and 8) proteins, which translocate with SMAD4 to the
nucleus. Hepcidin expression is induced after binding of
the P-SMAD complex to the BMP-responsive element in
the hepcidin promoter [9, 10]. Specific inhibitors of the
BMP signalling pathway present novel therapeutic op-
portunities in different diseases such as pulmonary arter-
ial hypertension, vascular calcification or AI [11, 12].
The hepatocyte-specific disruption of SMAD4, or
hepatocyte-specific deficiency of the BMP type I receptors
ALK2 or ALK3, cause moderate and severe iron overload
and hepcidin suppression, respectively [9, 13]. Mice with
hepatocyte-specific Smad4 deficiency display not only
attenuated baseline hepcidin expression, but also lack IL-6
mediated hepcidin expression [9]. In mice with
hepatocyte-specific Alk3 deficiency, neither iron nor BMP
agonists were able to stimulate hepcidin [13]. In a model
of acute inflammation, Mayeur et al. demonstrated, that
IL-6 induced hepatic hepcidin mRNA expression after
four (or 72) hours was dependent on the BMP type I re-
ceptor ALK3 [14]. In mice with hepatocyte-specific Alk3
deficiency STAT3 was phosphorylated by IL-6, but the
hepcidin induction was impeded and hepcidin levels
remained at about 1–5% compared to control mice in
short term experiments [13, 14]. The susceptibility of
these mice to develop AI had yet to be investigated. The
intraperitoneal application of a single dose of heat-killed
Brucella abortus (BA) particles was utilized in this study
to induce chronic inflammation and the development of
AI in mice. This well described murine model of AI fea-
tures the following hallmarks of the disease: i) early hepci-
din induction, ii) cytokine release and, iii) impaired
erythropoiesis [15–17].
We hypothesized that suppressed hepcidin levels and
iron overload in hepatocyte-specific Alk3 deficiency pro-
tect from AI development per se. Prior to BA or saline in-
jection and throughout the experiment, nutritional iron
was therefore restricted in all groups of mice in order to
maintain similar baseline iron levels in mice with and
without hepatocyte-specific Alk3 deficiency. In a previous
study, nutritional iron restriction did not alter the early BA
mediated induction of hepatic hepcidin mRNA levels or
BA mediated serum IL-6 induction in control mice [18].
As anaemia suppresses hepcidin expression per se, and
Kim et al. reported decreased hepcidin expression 14 days
after BA administration in WT mice due to anaemia,
STAT3 and SMAD1/5/8 phosphorylation were investi-
gated in a second model [16] : S. aureus was applied to
control and hepatocyte-specific Alk3 deficient mice on a
standard rodent chow and proteins were analysed 24 h
later. Upon S. aureus administration SMAD1/5/8 phos-
phorylation was detectable in control mice, but not in
mice with hepatocyte-specific Alk3 deficiency.
To conclude, various factors contribute to anaemia.
The presented data indicate that ALK3 and subsequently
hepcidin are involved in the cross-talk between iron and
inflammation, and contribute to at least 30% of the AI
development in this model. Therefore, ALK3 inhibition
could be an approach to ameliorate AI.
Methods
Animal research
Mice with homozygous loxP-flanked (“floxed”) Alk3 al-
leles (Alk3fl/fl) on a C57BL/6 background were bred with
B6.Cg-Tg(Alb-Cre)21Mgn/J mice (Jackson Laboratory) to
obtain homozygous animals (Alk3fl/fl) with or without
the hepatocyte-specific Cre recombinase driven by an
albumin promotor [19]. Mice with hepatocyte-specific
deficiency of Alk3 (Alk3fl/fl; Alb-Cre) were compared to
Alk3fl/fl mice without expression of the Alb-Cre as de-
scribed previously (on regular iron chow) [13]. In this
study, all mice were fed an iron-deficient diet since
weaning and throughout the experiment (5 ppm iron,
Altromin C1038, Lage, Germany).
Murine heat-killed Brucella abortus model and injection
with Staphylococcus aureus
All mouse experiments were carried out in accordance
with the recommendations and approval of the institu-
tional ethics committee for “Animal Care of North Rhine-
Westphalia, the Landesamt fuer Natur, Umwelt und
Verbraucherschutz (LANUV), North Rhine-Westphalia,
Germany” permit numbers LANUV Az.84–02.04.2013.
A281 and 87–51.04.2011.A003. Brucella abortus (BA,
Strain 99, Brucella abortus MRT AG PA 0048) was pre-
pared as described by Sasu et al. [17]. Mice were main-
tained according to institutional guidelines in individually
ventilated cages and were given food and water ad libitum.
12-week-old female mice were injected once with BA (5 ×
108 particles per mouse) or PBS intraperitoneally
(Additional file 1a). Fourteen days after BA administration,
mice had an average weight of 24 g ± 2,9. At that day
blood withdrawal and organ collection were performed,
when Hb levels reach nadir values [16]. Mice were sacri-
ficed by cervical dislocation in deep anaesthesia.
Staphylococcus aureus (S. aureus) strain 6850
(ATCC 53657, Manassas, VA) was cultivated overnight
in brain-heart infusion medium under shaking condi-
tions at 37 °C [20]. The bacteria were washed twice
with sterile PBS and the bacterial suspension was ad-
justed to optical density at 600 nm (OD600 = 1), and
stored at − 80 °C until use. Mice were inoculated with
1 × 106 colony forming units (CFUs) of S. aureus mi-
croorganisms in 150 μL of PBS or with PBS alone as
vehicle via a lateral tail vein. After 24 h, blood was col-
lected in deep anaesthesia (Additional file 1b). Then
mice were sacrificed by cervical dislocation and organs
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were collected. All animals were monitored daily. No
sudden deaths occurred.
Erythroid progenitor cells
Bone marrow (BM) was collected and processed as de-
scribed previously [21]. Cells were stained with APC-
conjugated rat-anti-mouse CD44 (BD Pharmingen,
Heidelberg, Germany) and PE-conjugated rat-anti-mouse
TER119 (BD Pharmingen, Heidelberg, Germany) in 2%
FBS/PBS for 30 min at RT protected from light. Analysis
was performed using the BD FACSDiva™ software on a
FACSCalibur™ (Becton Dickinson, Heidelberg, Germany).
Unstained cells were used as negative controls. Mean
fluorescence intensity (FLI) from 20.000 cell counts was
used as a measure of protein surface expression of Ter119
and CD44 [22–24].
Reticulocytes
Reticulocytes were counted by flow cytometry (FACSCali-
bur™, Becton Dickinson, Heidelberg, Germany). Blood
(5 μl) was added to 1 ml of thiazole orange reagent (Retic-
COUNT™, BD Bioscience; San Jose, CA) and incubated at
room temperature for 1 h. Unstained controls were used to
establish a gate to exclude background fluorescence. The
results are expressed as the reticulocyte production index:
RPI = Retic% x Hb/14.46, with 14.46 g/dL as the mean
baseline haemoglobin (Hb) level of healthy WT mice [18].
Hematologic and iron parameters
Blood samples were collected by retro-orbital punc-
ture and serum iron parameters were determined as
previously described [13]. Complete blood counts
were obtained with the scil Vet abc Plus™ (Viernheim,
Germany). Non-haem tissue iron levels were deter-
mined as previously described [25].
Hepatic mRNA levels
RNA was extracted from tissue using Trizol® (Sigma,
Hamburg, Germany) and homogenized with an ultra-
sound dissector. cDNA was created by MMLV-reverse
transcriptase (Sigma, Hamburg, Germany).
Quantitative RT-PCR was performed on an Applied
Biosystems 7500 Fast Real-Time-PCR system with Lumi-
noCt® SYBR® Green qPCR ReadyMix™ (Sigma, Hamburg,
Germany). The relative CT method was used to
normalize the levels of target transcripts to 18S rRNA
levels (Additional file 2).
Protein analysis
Liver tissue samples were prepared with RIPA buffer sup-
plemented with protease and phosphatase inhibitors
(Sigma-Aldrich, Heidelberg, Germany). Extracted proteins
(40 μg/lane) were separated by electrophoresis using 4%–
10% bis-tris gels and nitrocellulose membranes (GE
Healthcare, Freiburg, Germany). Membranes were incu-
bated with antibodies directed against phosphorylated
STAT3 (at tyrosine705 (P-STAT3, Cat. No. 9145 L, Cell
Signalling Technology)), STAT3 (Cat. No. 4904, Cell Sig-
nalling Technology), phosphorylated SMAD 1/5/8 (P-
SMAD 1/5, Cat. No. 9516S, Cell Signalling Technology),
SMAD1 (Cat. No. 6944, Cell Signalling Technology),
Ferroportin (Cat. No. MTP11-A, Alpha Diagnostics) and
α-tubulin (Cat. No. T6074, Sigma-Aldrich). Washed
membranes were incubated with horseradish peroxidase–
linked anti-rabbit or anti-mouse IgG (New England Bio-
labs, Frankfurt, Germany). Membranes were incubated
with ECL-Plus (Bio-Rad, Munich, Germany), and chemi-
luminescence was detected with a ChemiDoc™ XRS+ (Bio-
Rad, Munich, Germany). Densitometrical analysis was
performed with Image Lab™ (Bio-Rad, Munich Germany).
Statistical analysis
All values are expressed as mean ± SD. Data were analysed
using nonparametric Mann-Whitney U test with two
tailed P values. Differences were considered statistically
significant with P ≤ 0.05 (*).
Data availability
The data supporting the conclusions of this article are
included within the article and the Additional file 3.
Results
Hepatocyte-specific deficiency of Alk3 attenuated AI
development
Mice with hepatocyte-specific Alk3 deficiency fed a
standard rodent diet develop iron overload. Iron over-
load could protect these mice from anaemia. In order to
avoid development of the iron overload phenotype, mice
were fed an iron–deficient diet since weaning and
throughout the experiment. At the age of 12 weeks mice
were exposed to the heat-killed BA model of AI. Alk3
mRNA levels were suppressed in Alk3fl/fl; Alb-Cre mice
injected either with saline or with BA, and compared to
Alk3fl/fl control mice (Additional file 4). Fed an iron-
deficient diet, Alk3fl/fl; Alb-Cre and Alk3fl/fl control mice
injected with PBS expressed comparable Hb levels, re-
ticulocyte production index (RPI), serum iron levels and
transferrin saturation (Fig. 1a-d). Tissue iron content in
liver and spleen (Additional file 5) was comparable be-
tween control and hepatocyte-specific Alk3 deficient
mice. BA administration led to a slight increase in LIC
of hepatocyte-specific Alk3 deficient mice compared to
saline application in these mice. The results indicate that
development of the iron overload phenotype in Alk3fl/fl;
Alb-Cre compared to Alk3fl/fl mice was prevented by the
iron-deficient diet. Fourteen days after the intraperito-
neal injection of BA, Alk3fl/fl control mice developed an-
aemia indicated by a decrease of the mean Hb levels
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from 14.9 g/dl to 8.6 g/dl (Fig. 1a). In contrast, Alk3fl/fl;
Alb-Cre mice presented moderate anaemia with a de-
crease in Hb levels from 16.7 g/dl to 11.6 g/dl. As a de-
scription of the relative reduction, Hb levels in control
mice after BA administration were about one third lower
compared to Alk3 deficient mice after BA administra-
tion. The data indicate that mice with hepatocyte-
specific Alk3 deficiency were partially protected from
the development of AI and hypoferremia.
The RPI was increased in both groups after BA adminis-
tration (Fig. 1b) due to anaemia. Fed an iron-deficient diet
and injected with PBS, Alk3fl/fl; Alb-Cre mice and Alk3fl/fl
mice presented comparable serum iron levels and transfer-
rin saturation (Fig. 1c-d). Fourteen days after BA injection
Alk3fl/fl; Alb-Cre mice showed higher serum iron levels and
higher transferrin saturation compared to BA treated
Alk3fl/fl mice (Fig. 1c-d). In particular, the mean corpuscular
volume (MCV) and the mean corpuscular haemoglobin
(MCH) values were higher in Alk3fl/fl; Alb-Cremice injected
with BA than in Alk3fl/fl after BA injection (Fig. 2a-b).
While Alk3fl/fl mice fed an iron deficient diet and injected
with BA developed a microcytic, hypochromic AI, the
Alk3fl/fl; Alb-Cre mice treated equally, developed a normo-
cytic, normochromic AI with normal MCV and MCH
values (Fig. 2a-b).
In mice with hepatocyte-specific Alk3 deficiency BA in-
duced hepatic ferroportin mRNA levels. Protein levels
remained similarly high due to the hepcidin reduction
caused by hepatocyte-specific Alk3 deficiency (Fig. 3a-c).
Hepatic ferritin expression was induced after BA applica-
tion in control and in mice with hepatocyte-specific Alk3
deficiency (Additional file 6). Hepatic TfR1 expression was
elevated in hepatocyte-specific Alk3 deficient mice after
BA application. In control mice, a similar trend was ob-
served (Fig. 4a-b). Splenic ferroportin mRNA levels were
induced by BA in both, control and mice with hepatocyte-
specific Alk3 deficiency (Additional file 7). Splenic TfR1
mRNA levels were only elevated in control mice after BA
administration (Additional file 7).
These data indicate that the BA-mediated decrease
in serum iron levels led to an elevated extramedullary
erythropoiesis as indicated by increased hepatic TfR1
protein and splenic TfR1 mRNA levels in Alk3fl/fl;
Alb-Cre and Alk3fl/fl mice, respectively. Ferritin is not
only an iron storage marker, but also an acute phase
protein. Therefore, hepatic ferritin expression was in-
duced after BA application in control and in mice
with hepatocyte-specific Alk3 deficiency as part of the
acute phase reaction. LICs were slightly increased
(Additional files 5 and 6).
Fig. 1 Milder Anaemia of inflammation in Alk3fl/fl; Alb-Cre mice compared to Alk3fl/fl mice. a Haemoglobin values from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice
14 days after heat-killed Brucella abortus (BA) or saline injection (*P = 0.01: Alk3fl/fl injected with saline [n = 4] vs Alk3fl/fl injected with BA [n = 6]; *P = 0.01:
Alk3fl/fl; Alb-Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6]; *P = 0.04: Alk3fl/fl injected with BA [n = 6] vs Alk3fl/fl; Alb-Cre injected
with BA [n = 6]). b Reticulocyte Production Index (*P = 0.03: Alk3fl/fl injected with saline vs Alk3fl/fl injected with BA; *P = 0.01: Alk3fl/fl; Alb-Cre injected with
saline vs Alk3fl/fl; Alb-Cre injected with BA). c Serum iron from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice 14 days after BA administration (**P = 0.004: Alk3fl/fl
injected with BA vs Alk3fl/fl; Alb-Cre injected with BA). d Transferrin saturation (**P = 0.01: Alk3fl/fl injected with BA vs Alk3fl/fl; Alb-Cre injected with
BA [n = 5])
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There were no discernible differences detectable in
mRNA levels of ferroportin in the duodenum (Additional
file 7). However, immunofluorescence staining of duodenal
ferroportin of untreated mice with and without hepatocyte-
specific Alk3 deficiency indicated a stronger ferroportin ex-
pression on the luminal surface of the mucosa in mice with
hepatocyte-specific Alk3 deficiency compared to control
mice (Additional files 8 and 9). These data suggest that a
regional difference in ferroportin expression may result in
the better iron mobilization in mice with hepatocyte-
specific Alk3 deficiency.
Taken together, the data indicate that mice with
hepatocyte-specific deficiency of Alk3 under iron-restricted
conditions still developed AI after BA administration, but
to a milder extent than control mice. Due to the relative
reduction in haemoglobin levels, the contribution of the
ALK3/hepcidin/ferroportin circuitry to BA-mediated AI
was estimated with about 30%. Hepatocyte-specific Alk3
deficiency partly prevented the development of hypoferre-
mia and led to normocytic, normochromic erythrocytes.
The inflammatory response to BA administration was
intact in mice with hepatocyte-specific Alk3 deficiency
In order to determine the inflammatory response to
BA, mice with and without hepatocyte-specific Alk3
deficiency were analysed 14d after BA injection. AI
was accompanied by an induction of granulocytes
within comparable ranges after BA application in
Alk3fl/fl and Alk3fl/fl; Alb-Cre mice (Fig. 5a), which
Fig. 3 Hepatocyte-specific Alk3 deficiency resulted in elevated liver ferroportin expression 14 days after BA injection. a Relative hepatic ferroportin mRNA
levels (*P= 0.01: Alk3fl/fl; Alb-Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n= 6]; *P= 0.01: Alk3fl/fl injected with BA [n= 5] vs Alk3fl/fl;
Alb-Cre injected with BA [n= 6]). Representative Western blots (b) and quantitative analyses (c) of hepatic ferroportin protein levels with α-tubulin as
loading control
Fig. 2 MCV and MCH levels in Alk3fl/fl; Alb-Cre mice compared to Alk3fl/fl mice. a Mean corpuscular volume (MCV) (**P = 0.002: Alk3fl/fl injected with BA
vs Alk3fl/fl; Alb-Cre injected with BA), and b Mean corpuscular haemoglobin (MCH) (**P = 0.002: Alk3fl/fl injected with BA vs Alk3fl/fl; Alb-Cre injected
with BA)
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indicate comparable grades of chronic inflammation in
both groups. IL-6 and TNF-α mRNA levels were in-
duced in both, Alk3fl/fl; Alb-Cre and Alk3fl/fl mice, to a
similar extent (Fig. 5b-c). HO-1 mRNA expression
levels, a marker of oxidative stress, which is upregu-
lated by the IL-6/STAT3 signalling pathway, were ele-
vated in the liver of both, Alk3fl/fl and Alk3fl/fl; Alb-Cre
mice, after BA administration (Fig. 5d). IL-6 induces
SAA-1 mRNA levels. Therefore, BA administration led
to an increase in SAA-1 mRNA in Alk3fl/fl; Alb-Cre
and Alk3fl/fl mice (Fig. 6). Interestingly, SAA-1 mRNA
levels were markedly higher in Alk3fl/fl; Alb-Cre mice
compared to Alk3fl/fl mice injected with BA. Hepcidin
mRNA levels were suppressed 14d after BA-injection
in all four groups of mice (Additional file 10). These
data were expected, as the BA injection causes a hepci-
din increase after 6 h, which decreases in chronic, pro-
longed inflammation and iron deficiency after 14d. To
conclude, the BA-mediated inflammatory response was
not altered in mice with hepatocyte-specific Alk3 defi-
ciency. The elevated SAA-1 levels in mice with
hepatocyte-specific Alk3 deficiency might reflect the
failure of early hepcidin induction upon inflammation
and its anti-inflammatory properties.
Erythropoiesis was similar in Alk3fl/fl and Alk3fl/fl; Alb-Cre
mice after BA administration
To investigate whether an impaired erythropoiesis con-
tributed to AI, total BM cells were selected for Ter119
cell surface expression via fluorescence-activated cell
sorter to identify the amount of erythroid precursor
cells. Cells from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice ex-
hibited a similar reduction in their total erythroid cell
population (43% decrease in Alk3fl/fl mice compared
with 39% decrease in Alk3fl/fl; Alb-Cre mice. Ter119+
cells, Fig. 7a). To further distinguish the erythroid sub-
populations, cells were sorted by CD44 expression and
cell size (forward scatter). In later, further differentiated
stages of erythroblasts, the CD44 surface expression de-
clines (from proerythroblast to reticulocyte).
Gating for the Terr119+ cell population, the subpop-
ulations were analysed. BA administration led to an
upregulation in basophilic erythroblasts in Alk3fl/fl
mice only (population II, Fig. 7b). Polychromatic
Fig. 4 Hepatic protein levels of transferrin receptor 1. a Representative Western blots and quantitative analyses (b) of hepatic TfR1 protein levels
in Alk3fl/fl and Alk3fl/fl; Alb-Cre mice 14 days after heat-killed Brucella abortus (BA) injection. As loading control α-tubulin expression is depicted.
(*P = 0.03: Alk3fl/fl; Alb-Cre injected with saline vs Alk3fl/fl; Alb-Cre injected with BA)
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erythroblasts (population III) were upregulated in both
groups, but more pronounced in Alk3fl/fl; Alb-Cre
mice. BA administration resulted in a comparable de-
crease of terminal differentiated red cells from the BM
in both groups (terminal differentiated red cells, popu-
lation V, Fig. 7b). However, despite the differences in
erythroid precursor cell distribution between both
groups, BA administration led to an arrest in the mat-
uration of erythroid cells before they differentiated
into orthochromatic erythroblasts. This resulted in
equally suppressed numbers of terminal differentiated
red cells (population V) and the total of erythroid cells
(Ter119+) from the BM in both, Alk3fl/fl mice and
Alk3fl/fl; Alb-Cre mice. Additionally, the number of red
blood cells (RBCs) was equally decreased in both
groups after BA administration (Additional file 10).
The data reflect that BM erythropoiesis did not con-
tribute to the protection of BA-mediated AI in Alk3fl/
fl; Alb-Cre mice compared to controls. BA administra-
tion resulted in an impaired erythropoiesis of the BM
in both, Alk3fl/fl and Alk3fl/fl; Alb-Cre mice, with an ar-
rest in maturation prior to differentiation into ortho-
chromatic erythroblasts. The ratio of splenic weight/
body weight was comparable and indicate that both
Fig. 6 BA-induced SAA-1 mRNA levels in Alk3fl/fl; Alb-Cre mice and Alk3fl/
fl mice. Relative hepatic SAA-1 mRNA levels (*P = 0,01: Alk3fl/fl injected
with saline [n= 4] vs Alk3fl/fl injected with BA [n= 4]; *P = 0,01: Alk3fl/fl;
Alb-Cre injected with saline [n= 6] vs Alk3fl/fl; Alb-Cre injected with BA [n
= 6]; *P= 0.03: Alk3fl/fl injected with saline vs Alk3fl/fl; Alb-Cre injected with
saline; *P= 0.03: Alk3fl/fl injected with BA vs Alk3fl/fl; Alb-Cre injected with
BA). The relative CT method was used to normalize the levels of target
transcripts to 18S rRNA levels
Fig. 5 Comparable BA-induced inflammation in Alk3fl/fl; Alb-Cre mice and Alk3fl/fl mice. a Granulocytes from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice
14 days after heat-killed Brucella abortus (BA) or saline injection (*P = 0.01: Alk3fl/fl injected with saline [n = 4] vs Alk3fl/fl injected with BA [n = 4]; *P
= 0.01: Alk3fl/fl; Alb-Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6]), and (b) Relative hepatic IL-6 mRNA levels from Alk3fl/fl
and Alk3fl/fl; Alb-Cre mice 14 days after BA administration (*P = 0.03: Alk3fl/fl injected with saline [n = 3] vs Alk3fl/fl injected with BA [n = 5]; **P = 0.01:
Alk3fl/fl; Alb-Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6]). c Relative hepatic TNF-α mRNA levels (*P = 0.04: Alk3fl/fl
injected with saline [n = 3] vs Alk3fl/fl injected with BA [n = 4]; *P = 0.01: Alk3fl/fl; Alb-Cre injected with saline [n = 5] vs Alk3fl/fl; Alb-Cre injected with
BA [n = 6]). d Relative hepatic HO-1 mRNA levels (*P = 0.01: Alk3fl/fl injected with saline [n = 4] vs Alk3fl/fl injected with BA [n = 6]; *P = 0.01: Alk3fl/fl;
Alb-Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6])
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groups compensated for the impaired erythropoiesis of
the BM after BA administration with an enhanced
erythropoiesis in the spleen (Additional file 10). The
suppression of hepcidin develops due to the secretion
of erythroid factors, such as erythroferrone, by the
bone marrow. The way these erythroid factors repress
hepcidin expression is partly known: Wang et al.
showed that SMAD1/5 was required for erythropoietin
and erythroferrone mediated hepcidin suppression
[26]. As erythroferrone is proximal of BMP/SMAD sig-
nalling, there was no difference in erythroferrone mRNA
in liver and spleen of mice with and without hepatocyte-
specific Alk3 deficiency (Additional file 10).
Inhibition of BMP signalling did affect SMAD1/5/8
phosphorylation
In order to determine, if STAT3 phosphorylation was in-
tact in mice with and without hepatocyte-specific Alk3
deficiency, STAT3 phosphorylation was determined via
immunoblotting. BA-injection induces IL-6 and thereby
STAT3 phosphorylation. STAT3 phosphorylation was
present in Alk3fl/fl and Alk3fl/fl; Alb-Cre mice injected
Fig. 7 Bone marrow erythropoiesis depicted through total erythroid cells and distribution of erythroid precursor cell populations. a Total erythroid cells
(Ter119+) in the bone marrow 14 days after heat-killed Brucella abortus (BA) or saline injection (*P= 0.03: Alk3fl/fl injected with saline [n= 4] vs Alk3fl/fl
injected with BA [n= 6]; **P= 0.009: Alk3fl/fl; Alb-Cre injected with saline [n= 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6]). b Erythroid subpopulations in the
bone marrow of Alk3fl/fl and Alk3fl/fl; Alb-Cre mice 14d after BA administration (V and II: *P= 0.01: Alk3fl/fl injected with saline vs Alk3fl/fl injected with BA; III: *P
= 0.01: Alk3fl/fl injected with saline vs Alk3fl/fl injected with BA; III and V: *P= 0.01: Alk3fl/fl; Alb-Cre injected with saline vs Alk3fl/fl; Alb-Cre injected with BA, II: P
= 0.01: Alk3fl/fl injected with BA vs Alk3fl/fl; Alb-Cre injected with BA; III: P= 0.01: Alk3fl/fl injected with BA vs Alk3fl/fl; Alb-Cre injected with BA). [Subpopulation V
= terminal differentiated red cells, IV = orthochromatic erythroblast, III = polychromatic erythroblast, II = basophilic erythroblast, I = proerythroblast]
Fig. 8 Hepatic STAT3 and SMAD1/5/8 protein expression in Alk3fl/fl; Alb-Cre and Alk3fl/fl mice. Representative western blots (a) and quantitative analyses (b)
of phospho-STAT3 and total-STAT3 from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice 14 days after heat-killed Brucella abortus (BA) or saline injection. Two isoforms of
phospho-STAT3 α and β (79/86 kDa) exist. Loading control is indicated by total STAT3 protein levels. c SMAD1/5/8 activation 14d after BA administration in
Alk3fl/fl (Cre-) and hepatocyte-specific Alk3 deficient (Alk3fl/fl; Alb-Cre) (Cre+) mice fed an iron deficient diet. Western blots from liver proteins analysed with
phosphorylated SMAD1/5/8, total SMAD1, and α-tubulin antibodies. Arrows indicate specific pSMAD signal. d Densitometric analyses of the ratio of
SMAD1/5/8 to SMAD1
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with BA, but weaker in the latter (Fig. 8a-b). SMAD1/5/
8 baseline phosphorylation was detectable in control,
but not in Alk3 deficient mice. Fourteen days after BA
administration SMAD1/5/8 phosphorylation seems re-
duced in control mice and still absent in Alk3 deficient
mice (Fig. 8c-d). These results indicate that BMP signal-
ling is abrogated in mice with hepatocyte-specific Alk3
deficiency, so that ALK3 is the critical receptor for intact
BMP/SMAD signalling and that SMAD activation is re-
quired for the STAT3 pathway.
As SMAD1/5/8 phosphorylation, due to iron restriction
and anaemia, was not induced 14 days after heat-killed BA
administration, we administered the vital bacterium S. aur-
eus in another set of experiments to mice with and without
hepatocyte-specific Alk3 deficiency and analysed the protein
phosphorylation 24 h later. In mice with and without
hepatocyte-specific Alk3 deficiency, STAT3 phosphorylation
was detectable 24 h after the S. aureus injection (Fig. 9a-b).
SMAD1/5/8 phosphorylation was only detectable in control
mice 24 h after S. aureus administration (Fig. 9c).
To conclude, the inhibition of the SMAD1/5/8 signal-
ling pathway due to Alk3 deficiency partly suppressed
the induction of the STAT3 signalling pathway by BA or
S. aureus administration.
Discussion
AI is the second most common form of anaemia world-
wide. Pathophysiologically, AI is associated with elevated
cytokine levels, iron trapped in iron stores, iron re-
stricted erythropoiesis and hypoferremia. The current
manuscript reveals for the first time that hepatocyte-
specific Alk3 deficiency partly protects mice from devel-
opment of AI. The iron restricted diet fed prior to the
experiment prevented development of the iron overload
phenotype in Alk3fl/fl; Alb-Cre mice. After BA injection,
these Alk3fl/fl; Alb-Cre mice presented higher Hb levels,
serum iron levels, transferrin saturation, MCV, and
MCH compared to BA injected control mice. In con-
trast, the inflammatory response to BA administration
was not altered by hepatocyte-specific Alk3 deficiency as
indicated by comparably elevated granulocytes and cyto-
kine levels. BM erythropoiesis was equally suppressed in
control and Alk3fl/fl; Alb-Cre mice due to elevated cyto-
kine levels. The data indicate that ALK3 was required
for the cytokine mediated development of hypoferremia.
The ALK3-hepcidin axis accounted with about one third
to the development of AI. Therefore, ALK3 serves as a
possible therapeutic target for AI.
Of note, the BA model used in this study cannot be
compared to active bacterial infection, as heat-killed
Brucella abortus bacteria do not replicate. Nevertheless,
it is a well-known and frequently used model for AI that
was previously used to investigate AI by Kim, Sasu,
Kautz, Gardenghi and stated in a review by Fraenkel
[15–17, 27, 28]. The typical pathophysiological develop-
ment that leads to AI, an induction of hepcidin, is also
caused by the BA injection after 6 h independent from
iron restricted diet [16, 18].
The peptide hormone hepcidin has been reported to
play an important role in development of AI [29]. Mice
lacking hepcidin (Hamp-KO) fed an iron-deficient diet
showed milder anaemia and faster recovery after BA ad-
ministration compared to control mice [15, 16]. The IL-
6/hepcidin signalling pathway plays a major role in the
development of anaemia in an inflammatory condition.
Steinbicker et al. demonstrated that the hepatocyte-
specific deficiency of the BMP type I receptor ALK3 not
only led to a suppression of basal hepcidin expression
Fig. 9 Hepatic protein levels of STAT3 and SMAD1/5/8. Representative western blots (a) and quantitative analyses (b) of hepatic phospho-STAT3 and total-
STAT3 protein expression from Alk3fl/fl (Cre-) and Alk3fl/fl; Alb-Cre (Cre+) mice 24 h after S. aureus administration. Two isoforms of phospho-STAT3 α and β
(79/86 kDa) exist. Loading control is depicted by total STAT3 protein levels. c Hepatic protein expression of phospho-SMAD1/5/8, SMAD1, and α-tubulin
from Alk3fl/fl (Cre-) and Alk3fl/fl; Alb-Cre (Cre+) mice 24 h after S. aureus administration
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and iron overload (mice on a regular diet), but that
ALK3 was required for the hepatic hepcidin mRNA in-
duction by iron, BMP ligands and IL-6 [13, 30]. Based
upon these findings, we investigated the effect of the
hepatocyte-specific Alk3 deficiency on the development
of AI in a well described mouse model for AI [15–17].
Even with an abolished iron overload phenotype in
Alk3fl/fl; Alb-Cre mice fed an iron-restricted diet the
hepatocyte-specific Alk3 deficiency had a partially pro-
tective effect on the development of anaemia. The BMP
type I receptor–SMAD-hepcidin signalling pathway con-
tributed - as described in this manuscript - with about
30% to the development of anaemia in Alk3fl/fl; Alb-Cre
mice. Kim et al. and Gardenghi et al. reported for
Hamp-KO and IL-6-KO mice similar findings with a
protection of about 30% to the development of BA-
induced anaemia [15, 16]. Pan et al. reported that
Smad4-deficient mice developed severe anaemia with a
decrease in their Hb levels by 70% compared to WT
mice, which was not only due to hepcidin suppression in
the liver, but due to blood loss caused by polyps in the
stomach and colon of these mice [31]. Alk3fl/fl; Alb-Cre
mice displayed higher serum iron, Hb, transferrin satur-
ation, MCV, and MCH levels compared to control mice
after BA administration despite the iron-deficient diet.
This indicates that the lack of hepatic hepcidin expres-
sion in Alk3fl/fl; Alb-Cre mice led to alterations in iron
metabolism. An enhanced haemoglobinisation of RBCs
contributed to the partial protection from anaemia.
Production of pro-inflammatory cytokines in inflamma-
tion triggers the development of anaemia via induction of
hepcidin. In Alk3fl/fl; Alb-Cre mice the induction of hepci-
din was inhibited. BA administration led to an up-
regulation of hepatic IL-6, TNF-α, and HO-1 mRNA levels
in both, Alk3fl/fl and Alk3fl/fl; Alb-Cre mice, and higher
SAA-1 mRNA levels in the latter. Granulocytosis indicates
a chronic inflammation in both control and Alk3 deficient
mice. These data indicate that the inflammatory response
was intact in both groups. The lack of early cytokine-
induced hepcidin expression (after 6 h) might have caused
the induction of SAA-1 mRNA levels in mice with
hepatocyte-specific Alk3 deficiency. In erythroferrone-
deficient mice Kautz et al. not only observed a more severe
AI upon BA administration (due to a lack of hepcidin sup-
pression), but also lower SAA-1 levels accompanied by
higher hepcidin levels [27]. Additionally, Pagani et al. ob-
served higher SAA-1 levels after LPS administration in mice
with iron-deficiency [32]. Pre-treatment with hepcidin or
high serum levels such as in Tmprss6−/− mice led to blunted
inflammatory responses (and lower SAA-1 levels) [32].
Wang et al. reported that mice with hepatocyte-specific
Smad4 deficiency show a lack of hepcidin induction and
display elevated SAA-1 levels upon IL-6 administration [9].
The results indicate that the lack of hepcidin and not iron
deficiency per se accounted for the elevated SAA-1 levels.
These results are in line with the data presented in the
current manuscript.
As expected, BA or S. aureus administration did not in-
duce SMAD1/5/8 phosphorylation in mice with
hepatocyte-specific Alk3 deficiency. In control mice, S. aur-
eus, but not BA application, led to an induction of
SMAD1/5/8 phosphorylation. This might be due to the
pronounced anaemia 14d after BA application. STAT3
phosphorylation was induced in control mice after BA or S.
aureus administration. In mice with hepatocyte-specific
Alk3 deficiency, the induction was lower compared to
Alk3fl/fl mice. The data indicate that STAT3 phosphoryl-
ation requires intact BMP signalling.
The elevated hepatic ferroportin level and the protection
from hypoferremia in hepatocyte-specific Alk3 deficient
mice indicate that the blunted BMP/SMAD signalling mod-
ulated the iron status in AI.
These results are in line with Ferga-Falzacappa et al.,
who determined the essential role of the SMAD binding
element of the hepcidin promoter for hepcidin induction
[10]. Furthermore Steinbicker et al. demonstrated that
inhibition with the BMP type I receptor inhibitor LDN-
193189 intraperitoneally, treated AI in wild-type mice
[30]. Mayeur et al. reported that LDN-193189 given or-
ally at a dose of 1 mg/kg to WT mice partially treated
turpentine induced anaemia [33]. Taken together, the
novel data of in vivo experiments of chronic inflamma-
tion in mice with and without hepatocyte-specific Alk3
deficiency exposed to the BA and S. aureus model
underline that ALK3 is the dominant BMP type I recep-
tor of iron regulation in inflammation.
Conclusion
The current manuscript revealed in vivo for the first
time that 1.) the previously described iron overload
phenotype of hepatocyte-specific Alk3 deficient mice
could be blunted by iron restricted diet and, 2.)
hepatocyte-specific Alk3 deficient mice were protected
against development of severe AI. The results of the
chronic model of inflammation and AI support the find-
ings of short term exposure to IL-6 in these mice, pub-
lished previously [14]. ALK3 was essentially required for
IL-6 and BA mediated hepcidin induction. As hypothe-
sized previously in cell culture studies and short term
experiments, the BA-AI in vivo experiment of chronic
inflammation revealed that the BMP pathway with the
dominant receptor ALK3 is essentially required for in-
tact hepcidin induction by inflammation, the develop-
ment of hypoferremia, and partly for the development of
AI. The inflammatory IL-6-STAT3 pathway should not
be seen as an independent pathway- it depends on an in-
tact BMP pathway.
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diet since weaning and throughout the experiment. At the age of 12 weeks,
female Alk3fl/fl; Alb-Cre and Alk3fl/fl mice were intraperitoneally injected with
5 × 108 particles/mouse of heat-killed Brucella abortus (BA) or saline. Two
weeks later blood and organs were collected. (b) 12 week old Alk3fl/fl; Alb-Cre
and Alk3fl/fl female mice fed a regular diet were intravenously inoculated with
1 × 106 colony forming units (CFUs) of Staphylococcus aureus. Twenty-four
hours later blood and organs were collected. (TIFF 164 kb)
Additional file 2: Table S1. Semi-quantitative real-time PCR primer.
(DOCX 15 kb)
Additional file 3: Raw data and analysis of the presented study.
(XLSX 18 kb)
Additional file 4: Hepatocyte-specific Alk3 deficiency resulted in suppressed
liver Alk3 and hepcidin mRNA expression. Relative hepatic Alk3 mRNA levels
from Alk3fl/fl and Alk3fl/fl; Alb-Cre 14 days after heat-killed Brucella abortus (BA)
injection (*P= 0.03: Alk3fl/fl injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre saline
[n= 4]; **P= 0.004: Alk3fl/fl injected with BA [n= 6] vs Alk3fl/fl; Alb-Cre injected
with BA [n= 6]. (TIFF 65 kb)
Additional file 5: Liver and spleen iron content from Alk3fl/fl and Alk3fl/fl; Alb-
Cre mice 14 days after BA challenge. (a) Liver iron content in Alk3fl/fl and Alk3fl/
fl; Alb-Cre mice 14 days after heat-killed Brucella abortus (BA) injection (*P=
0.04: Alk3fl/fl; Alb-Cre injected with saline [n= 4] vs Alk3fl/fl; Alb-Cre injected with
BA [n = 6]). (b) Spleen iron content from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice
14 days after heat-killed Brucella abortus (BA) injection. (TIFF 82 kb)
Additional file 6: Hepatic ferritin expression in Alk3fl/fl and Alk3fl/fl;Alb-Cre
mice 14 days after BA challenge. Representative western blots (a) and
quantitative analyses (b) of hepatic ferritin protein levels in Alk3fl/fl and Alk3fl/
fl; Alb-Cre mice 14 days after heat-killed Brucella abortus (BA) injection. As
loading control α-tubulin expression is depicted. (TIFF 270 kb)
Additional file 7: Spleen and duodenum mRNA levels in Alk3fl/fl and Alk3fl/
fl;Alb-Cre mice 14 days after BA challenge. (a) Relative splenic ferroportin mRNA
levels from Alk3fl/fl and Alk3fl/fl; Alb-Cre 14 days after heat-killed Brucella abortus
(BA) injection (*P= 0.02: Alk3fl/fl injected with saline [n= 4] vs Alk3fl/fl injected
with BA [n= 5]; *P= 0.03: Alk3fl/fl; Alb-Cre injected with saline [n= 4] vs Alk3fl/fl;
Alb-Cre injected with BA [n= 4]. (b) Relative splenic TfR1 mRNA levels (*P=
0.01: Alk3fl/fl injected with saline [n = 4] vs Alk3fl/fl injected with BA [n= 6]). (c)
Relative duodenal ferroportin mRNA levels. The relative CT method was used
to normalize the levels of target transcripts to 18S rRNA levels. (TIFF 103 kb)
Additional file 8: Immunofluorescence staining of ferroportin in the
duodenum of Alk3fl/fl and Alk3fl/fl; Alb-Cre mice. Ferroportin
immunofluorescence staining of formalin fixed paraffin sections of the
villosities of the duodenum with 20 times magnification. (Panel a) Control
mice with nuclear (DAPI) and ferroportin (FITC) staining of a duodenal
section. Cutout images merged (nuclear and ferroportin) and ferroportin
(FITC) alone. (Panel b) Duodenal section of hepatocyte-specific Alk3 deficient
mice with cutout images merged (nuclear and ferroportin) and ferroportin
(FITC) alone. White arrows highlight specific FPN staining. (TIFF 3601 kb)
Additional file 9: Supporting material and references. (DOCX 14 kb)
Additional file 10: Hepatic hepcidin mRNA levels, red blood cell count,
spleen to bodyweight ratio, and hepatic erfe mRNA levels of Alk3fl/fl;
Alb-Cre mice and Alk3fl/fl mice. (a) Relative hepatic hepcidin mRNA levels
compared to control mice fed a regular diet. The relative CT method was
used to normalize the levels of target transcripts to 18S mRNA levels. (b)
Red blood cell count from Alk3fl/fl and Alk3fl/fl; Alb-Cre mice 14 days after
heat-killed Brucella abortus (BA) injection (*P = 0.01: Alk3fl/fl injected with
saline [n = 4] vs Alk3fl/fl injected with BA [n = 6]; *P = 0.02: Alk3fl/fl; Alb-Cre
injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6]). (c)
Spleen to bodyweight ratio in Alk3fl/fl and Alk3fl/fl; Alb-Cre mice 14 days
after heat-killed Brucella abortus (BA) injection (*P = 0.01: Alk3fl/fl injected
with saline [n = 4] vs Alk3fl/fl injected with BA [n = 6]; *P = 0.01: Alk3fl/fl; Alb-
Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA [n = 6]).
(d) Relative hepatic erfe mRNA levels of Alk3fl/fl and Alk3fl/fl; Alb-Cre mice
14 days after heat-killed Brucella abortus (BA) injection (*P = 0.01: Alk3fl/fl;
Alb-Cre injected with saline [n = 4] vs Alk3fl/fl; Alb-Cre injected with BA
[n = 5]). (TIFF 129 kb)
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